Home
Biocon

Biocon Market Share Analysis for August 2026

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe.

Food and Drink > Food and Drink - Other

Domainbiocon.co.jp

Year Founded1978

Employees> 10001

Annual Revenue> $1B

Biocon

Biocon (including company regionals)

biocon.co.jp

See more website traffic and engagement information

Biocon Revenue up to August 2026 is > 1B

revenue generated by Biocon top domains

Biocon top domains revenue over 3 years

Revenue for Biocon top domains

biocon.co.jp> 1B

See more with Sales Intelligence

Biocon Stock price in August 2026

Biocon stock is traded under the ticker #BIOCON. Below you can review Biocon stock performance in the past 12 months up to August 2026

Total visits to Biocon's top domains

Understand Biocon market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biocon.co.jp2K

See more with Sales Intelligence

Avg. visit duration in Biocon's top domains

Analyze Biocon engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biocon.co.jp00:00:12

See more with Sales Intelligence

Avg. pageviews on Biocon's top domains

See how Biocon keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biocon.co.jp1.42

See more with Sales Intelligence

Biocon top competitors by domain

Top similar sites in August 2026, ranked by their affinity

kinositasouen.jpCompany Name草苑（そうえん）Employees51 - 200HQJapanAnnual revenue--Total visits8.7KFood and Drink > Food and Drink - Other

Top technologies used by Biocon

These are the website technologies, by industry, used by Biocon top domains

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

Social (2)

Instagram

Conversion & Analytics (1)

Google Analytics

More Technologies

4

See all

News & Signals from Biocon

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiocon launched Tacrolimus capsules in the U.S. Tacrolimus on Dec 1st '20.For instance, in December 2020, Biocon, an innovation-led global biopharmaceutical company, announced the launch of Tacrolimus capsules in the U.S. Tacrolimus is a calcineurin inhibitor, an immunosuppressant used in the treatment of organ transplant patients that reduces the body’s ability to reject a transplanted organ.